Cipla may witness a block of shares worth Rs 2,637 crore being traded on May 15, as sources inform CNBC-Awaaz that the promoter family and Okasa Pharma are set to sell up to a 2.53 percent stake. The anticipated price range for the Cipla block deal is between Rs 1,289.50 and Rs 1,357.35, representing a maximum discount of 5 percent. Sources further reveal that Kotak Securities is the exclusive broker for the block deal. Additionally, sellers are subjected to a 90-day lock-in period following the scheduled block trade.
Trending
- Supreme Court Tax Ruling: Cruise Operator Eligible for Section 44B Presumptive Taxation
- Supreme Court on BPCL, HPCL CNG Sales: Service Tax Applicable on Commission, Says Court
- Indian Household Savings Are Moving From Gold and Real Estate to Financial Assets
- Q1 Results FY27: 1,700 Companies to Announce June Quarter Earnings; Vodafone Idea, Bharat Forge, HAL, Tata Motors in Focus
- Jharkhand Students Protest Enters Day 16: Hemant Soren Promises Justice, Talks Resume Amid Exam Irregularity Row
- Delhi Red Fort Independence Day Security: 20,000 Personnel, 1,000+ CCTV Cameras Deployed Ahead of August 15
- Oswal Pumps Q1 Results 2026: Profit Falls 43%, Order Book Stands at 22,025 Pumps; Solar EPC Order Book at 72 MW
- PNG Jewellers Stock in Focus: Launches YOOU Flagship Store in Pune, Plans Nationwide Expansion
- Gland Pharma Stock in Focus: Company Signs Strategic CDMO Deal, Revenue Potential of $100 Million
- Hindustan Zinc Shares in Focus: Vedanta-Linked $80 Million Facility Repaid, Restrictions on HZL Lifted
Ensuring Authenticity, Upholding Trust
